Latest U.S. Recalls — FDA & NHTSA Records

Latest records

Latest recalls — page 76

The newest recall records with useful source details are listed here.

DrugApr 22, 2026

Lidocaine HCl injection, USP, 1% 50mg/5mL (10 mg/mL), 5 mL Single Dose Vials recall — FDA D-0529-2026

Lack of Assurance of Sterility

Class IIFDA: OngoingHuons Co., Ltd.

DrugApr 22, 2026

Bupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection, USP (15 mg/2 mL) (7.5 mg/mL) recall — FDA D-0530-2026

Lack of Assurance of Sterility

Class IIFDA: OngoingHuons Co., Ltd.

DrugApr 22, 2026

Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle recall — FDA D-0450-2026

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Class IIFDA: OngoingCipla USA, Inc.

DrugApr 22, 2026

caring mill, Menthol Cough Suppressant Oral Anesthetic, Cough Drops, Cherry, 90-count bag recall — FDA D-0458-2026

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on…

Class IIFDA: OngoingXiamen Kang Zhongyuan Biotechnology Co., Ltd.

DrugApr 22, 2026

Owen Biosciences SLMD Benzoyl Peroxide Acne Lotion, Benzoyl Peroxide 2.5%, a) 0.7 fl. oz recall — FDA D-0455-2026

Chemical contamination: Presence of benzene

Class IIFDA: OngoingOwen Biosciences Inc.

DrugApr 22, 2026

QUALITY CHOICE COUGH DROPS VANILLA HONEY QC Quality Choice, Menthol-Cough Suppressant Oral recall — FDA D-0470-2026

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on…

Class IIFDA: OngoingXiamen Kang Zhongyuan Biotechnology Co., Ltd.

DrugApr 22, 2026

MENTHOL FLAVOR COUGH DROP exchange select, Menthol- Cough Suppressant Oral Anesthetic, Cough recall — FDA D-0457-2026

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on…

Class IIFDA: OngoingXiamen Kang Zhongyuan Biotechnology Co., Ltd.

DrugApr 22, 2026

QUALITY CHOICE COUGH DROPS CREAMY STRAWBERRY QC Quality Choice, Pectin Oral Demulcent recall — FDA D-0467-2026

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on…

Class IIFDA: OngoingXiamen Kang Zhongyuan Biotechnology Co., Ltd.

DrugApr 22, 2026

QUALITY CHOICE QC Quality Choice, Menthol- Cough Suppressant Oral Anesthetic, Cough Drops recall — FDA D-0464-2026

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on…

Class IIFDA: OngoingXiamen Kang Zhongyuan Biotechnology Co., Ltd.

DrugApr 22, 2026

QUALITY CHOICE QC Quality Choice, Menthol-Cough Suppressant Oral Anesthetic, Cough Drops recall — FDA D-0468-2026

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on…

Class IIFDA: OngoingXiamen Kang Zhongyuan Biotechnology Co., Ltd.

DrugApr 22, 2026

FLUOCINONIDE recall — FDA D-0475-2026

Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Class IIFDA: OngoingSUN PHARMACEUTICAL INDUSTRIES INC

DrugApr 22, 2026

Discount Drug Mart Food Market, Cough Drops, Menthol- Cough Suppressant Anesthetic, Honey recall — FDA D-0459-2026

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on…

Class IIFDA: OngoingXiamen Kang Zhongyuan Biotechnology Co., Ltd.

DrugApr 22, 2026

QUALITY CHOICE QC Quality Choice, Menthol-Cough Suppressant Oral Anesthetic, Cough Drops recall — FDA D-0466-2026

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on…

Class IIFDA: OngoingXiamen Kang Zhongyuan Biotechnology Co., Ltd.

DrugApr 22, 2026

Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle recall — FDA D-0451-2026

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Class IIFDA: OngoingCipla USA, Inc.

DrugApr 22, 2026

FLUOCINONIDE recall — FDA D-0477-2026

Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Class IIFDA: OngoingSUN PHARMACEUTICAL INDUSTRIES INC

DrugApr 22, 2026

Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses) recall — FDA D-0510-2026

Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.

Class IIFDA: OngoingApotex Corp.

DrugApr 22, 2026

Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle recall — FDA D-0449-2026

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Class IIFDA: OngoingCipla USA, Inc.

DrugApr 22, 2026

HONEY LEMON FLAVOR COUGH DROP exchange select, Menthol -Cough Suppressant Oral Anesthetic recall — FDA D-0456-2026

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on…

Class IIFDA: OngoingXiamen Kang Zhongyuan Biotechnology Co., Ltd.

DrugApr 22, 2026

Discount Drug Mart Food Market, Cough Drops, Menthol -Cough Suppressant Anesthetic, 30-count recall — FDA D-0460-2026

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on…

Class IIFDA: OngoingXiamen Kang Zhongyuan Biotechnology Co., Ltd.

DrugApr 22, 2026

MGC HEALTH recall — FDA D-0461-2026

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on…

Class IIFDA: OngoingXiamen Kang Zhongyuan Biotechnology Co., Ltd.

DrugApr 22, 2026

MGC HEALTH recall — FDA D-0462-2026

This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on…

Class IIFDA: OngoingXiamen Kang Zhongyuan Biotechnology Co., Ltd.

DrugApr 22, 2026

FLUOCINONIDE recall — FDA D-0476-2026

Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Class IIFDA: OngoingSUN PHARMACEUTICAL INDUSTRIES INC

VehicleApr 21, 2026

Hyundai Motor side impact recall — NHTSA campaign 26V254000

Hyundai Motor America (Hyundai) is recalling certain 2025 Elantra N, 2026 Tucson, Tucson Hybrid, Tucson Plug-In Hybrid Electric (PHEV), and Elantra vehicles. The B-pillar impact sensors may…

side impactHyundai Motor America

Medical DeviceApr 15, 2026

Beckman Coulter MicroScan Neg Multidrug Resistant MIC 1 REF C32368 UDI-DI code recall — FDA Z-1794-2026

Due to manufacturing issue (incorrectly processing) with in vitro multidrug resistant test.

Class IIFDA: OngoingBeckman Coulter, Inc.

Browse by month

Recent recall archives

Browse recent months with enough recall history for useful comparison.

Full archive →